Leukemia treatment in Istanbul, Turkey
Leukemia is a cancer of the blood-forming tissues, including the bone marrow, and its four main types — acute lymphoblastic (ALL), acute myeloid (AML), chronic lymphocytic (CLL) and chronic myeloid (CML) — are treated very differently. Chemotherapy given in phases is the mainstay for many, while targeted tyrosine kinase inhibitors, immunotherapy including CAR T-cell therapy, and stem cell (bone marrow) transplant are used for the cases that call for them. Istanbul hospitals offer this full pathway, often at JCI-accredited, state-authorized centers and well below Western-European prices for the same protocol. Every price we show is an illustrative placeholder until verified partner-hospital quotes exist — and you pay the hospital directly, never us. Start with a free 72-hour review of your reports before you decide anything.
What leukemia is
The U.S. National Cancer Institute describes leukemia as cancer of the blood-forming tissues, including the bone marrow, where abnormal white blood cells build up and crowd out the healthy cells the body needs. The NCI groups it into four main types — acute lymphoblastic (ALL), acute myeloid (AML), chronic lymphocytic (CLL) and chronic myeloid (CML) — and the type strongly changes how it is treated. Acute types tend to come on quickly, while chronic types often progress slowly.
Diagnosis usually starts with blood tests that show abnormal counts, followed by a bone marrow biopsyand cytogenetic and molecular testing that identify the exact subtype and features such as the Philadelphia chromosome. Because the molecular subtype drives the plan more than almost anything else, this workup is not a formality — it is what tells the team which of the treatments below actually apply. Browse the wider cancer types hub for related diagnoses.
Treatment options
The modalities the NCI lists for leukemia, and an honest note on each:
- Chemotherapy. The mainstay for many leukemias, and for the acute types it is often given in distinct phases over months to bring the disease under control and then keep it there. Cost and length scale with the number of phases and any hospital stay. How chemotherapy works.
- Targeted therapy. For CML with the BCR-ABL fusion (the Philadelphia chromosome), a daily tyrosine kinase inhibitor such as imatinib can control the disease for years, often without intensive chemotherapy. Whether a targeted drug applies is decided by your molecular testing. How targeted therapy works.
- Immunotherapy, including CAR T-cell therapy. Monoclonal antibodies and, for some relapsed or refractory B-cell ALL, CAR T-cell therapy — in which a patient’s own T cells are re-engineered to attack the cancer — are used in selected situations, not as a first step. See immunotherapy in general.
- Stem cell (bone marrow) transplant. After high-dose therapy, a stem cell transplant can rebuild the blood-forming system for selected, often higher-risk or relapsed cases. It is an intensive treatment reserved for particular situations, not a default.
Because some chronic leukemias are managed for years and the molecular subtype drives the plan, no two leukemia journeys look alike. See how these modalities work in general on the treatments & technology hub.
What it costs
There is no single leukemia price, because the cost is driven by the type, the drugs used, the number of chemotherapy phases, the length of any hospital stay, and whether a stem cell transplant or CAR T-cell therapyis involved — those sit at very different price levels, while a daily targeted tablet for some chronic leukemias sits at another. Every figure OncologyIstanbul™ publishes today is an illustrative placeholder pending verified partner-hospital quotes, and each is itemized so you can hold a real quote up against it line by line. See the Turkey Oncology Price Index or the full cancer treatment cost in Turkey breakdown.
The hospital, verified
We don’t show a wall of smiling hematologists or a “ranked” list — those are the easiest things to fabricate. Instead, you’re matched to one state-authorized Istanbul partner hospital whose hematology and bone-marrow-transplant capability fits your diagnosis, and you can verify its authorization against the Republic of Turkey Ministry of Health’s own records and its JCI accreditation in JCI’s public directory before you commit. Named specialist profiles appear only when a verified, consented physician is behind the name. See the full guide to cancer hospitals in Istanbul and how to check one yourself.
Where this fits
This is one diagnosis within the broader cancer treatment in Istanbul pillar. If you want your own reports read first, a free second opinion organizes and verifies your blood counts, marrow report and cytogenetic testing into a plain-language case file in your language before you decide whether to travel.
Related cancers
Check everything here — us included
Common questions
Can I get leukemia treatment in Turkey?
Yes. Istanbul hospitals provide the full leukemia pathway the U.S. National Cancer Institute describes — phased chemotherapy, targeted drugs such as tyrosine kinase inhibitors, immunotherapy including monoclonal antibodies and CAR T-cell therapy in selected cases, and stem cell (bone marrow) transplant for those who need it. Because leukemia is a blood and bone-marrow cancer rather than a solid tumour, the plan depends heavily on the exact type and its molecular features, confirmed by blood tests and a bone marrow biopsy. Many centers hold JCI accreditation and Turkish Ministry of Health state authorization, both of which you can check yourself. The honest first step is a free case review of your blood counts, marrow report and cytogenetic testing.
How does leukemia treatment differ between acute and chronic types?
It differs a great deal. The NCI groups leukemia into four main types — acute lymphoblastic (ALL) and acute myeloid (AML), which come on quickly and usually need prompt, intensive phased chemotherapy, and chronic lymphocytic (CLL) and chronic myeloid (CML), which often progress slowly. Some chronic leukemias are managed for years, and CML in particular is frequently controlled with a daily targeted tyrosine kinase inhibitor rather than intensive chemotherapy. Certain slow-growing chronic leukemias with no symptoms may even be watched carefully before any treatment starts. The molecular subtype, not just acute versus chronic, ultimately drives the plan, which is why full marrow and genetic testing matters so much.
When is a stem cell transplant or CAR T-cell therapy needed?
Not for everyone, and never as a default. The NCI describes stem cell (bone marrow) transplant, given after high-dose chemotherapy, as an option for selected cases — often higher-risk or relapsed disease where a new blood-forming system is needed. CAR T-cell therapy, in which a patient's own T cells are re-engineered to attack the cancer, is used for some relapsed or refractory B-cell ALL and specific other blood cancers, not as a first step. Both are intensive treatments reserved for particular situations decided by a hematology team. A case review will flag whether your reports point toward transplant or CAR-T being relevant, but the decision belongs to the treating clinicians.
How much does leukemia treatment cost in Istanbul?
There is no single figure, because leukemia care can run from a daily targeted tablet for some chronic leukemias to months of phased chemotherapy, and in selected cases a stem cell transplant or CAR T-cell therapy — treatments that sit at very different price levels. The type, the drugs used, the length of hospital stay and whether a transplant is involved all move the total. Istanbul typically runs well below Western-European prices for the same protocol, but every figure OncologyIstanbul™ publishes today is an illustrative placeholder pending verified partner-hospital quotes, itemized so you can check a real written quote line by line. You pay the hospital directly, never us. See the Turkey Oncology Price Index for current ranges.
Start with a free 72-hour case review
Send your blood counts, marrow report and imaging. Get a verified case file in your language — free, confidential, no obligation.
This page is general information, not medical advice. Medical facts are grounded in the U.S. National Cancer Institute; prices shown are illustrative placeholders pending verified partner-hospital quotes, not offers. Every cancer case is individual; assessments are based on the reports you provide and do not replace in-person examination.